£1.30m
−19%vs Dec 2024Active08322695Private limited companyChester
MEDTECHTOMARKET CONSULTING LTD
Significant control: Matthew Leslie Pearce (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Medtechtomarket Consulting Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Medtechtomarket Consulting Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
MEDTECHTOMARKET CONSULTING LTD is an active private limited company (company number 08322695) incorporated on 7 December 2012, registered in Chester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £1.30m and cash of £567k, with 29 employees on average. Net assets fell 19% on the prior period (£1.61m).
Peer position · net assets
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Dr Matthew Leslie Pearce
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 7 December 201213 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 21 December 2026in 58 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£567k
−18%vs Dec 2024Not reported
29
+16%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £1.30m | £567k | £410k | £265k | — | — | 29 |
| 31 December 2024 | £1.61m | £692k | £722k | £502k | — | — | 25 |
Current ratio3.85Current assets ÷ creditors within one year
Cash per employee£20kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,304,852 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 3.85
- Cash at bank of £50,000 or moreCash £566,736
- Incorporated five or more years agoIncorporated 7 December 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 341 days
- Confirmation statement duein 58 days
- Accounts period endNet assets £1.30m · small accounts
- Accounts period endNet assets £1.61m · small accounts
- Incorporated
08
Similar companies in Liverpool
- JON MORROW LTDLiverpool · inc. Oct 2012
- AGROGEN LIMITEDLiverpool · inc. Apr 2013
- REACTA BIOTECH LIMITEDDeeside · inc. Jun 2013
- OXFORD BIOANALYTICAL TESTING LIMITEDLiverpool · inc. Sept 2013
- EXTENTUS PHARMA LTDLiverpool · inc. Mar 2014
- NANO BIOSOLS LTDLiverpool · inc. Oct 2014
All companies incorporated on 7 December 2012 · in Dec 2012.
09
Reminders for MEDTECHTOMARKET CONSULTING LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.